Inventor · Philadelphia, PA, US

Can Mao

13Patents

5h-index

50Co-inventors

65Inventor score

Filing activity: Dec 6, 2003 → Oct 15, 2018

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7879873B2	Azaindazole compounds as CCR1 receptor antagonists	Human Necessities	15	Active
US6974870B2	Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses	Chemistry; Metallurgy	10	Expired
US8063065B2	Azaindazole compounds as CCR1 receptor antagonists	Human Necessities	10	Active
US8293917B2	Pyrazole compounds as CCR1 antagonists	Chemistry; Metallurgy	7	Active
US8008327B2	Indazole compounds as CCR1 receptor antagonists	Chemistry; Metallurgy	6	Active
US8263597B2	Indazole compounds as CCR1 receptor antagonists	Chemistry; Metallurgy	5	Active
US10138229B2	Heteroaromatic compounds as BTK inhibitors	Chemistry; Metallurgy	2	Active
US10875852B2	Heteroaromatic compounds as BTK inhibitors	Chemistry; Metallurgy	2	Active
US7329764B2	Substitute benzothiophene compounds	Chemistry; Metallurgy	1	Expired
US8163918B2	Azaindazole compounds as CCR1 receptor antagonists	Human Necessities	0	Active
US9828364B2	Pyrazole compounds as BTK inhibitors	Chemistry; Metallurgy	0	Active
US9056858B2	Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists	Chemistry; Metallurgy	0	Active
US8546442B2	Pyrazolopiperidine compounds as CCR1 receptor antagonists	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.